rs81002830

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000059.4(BRCA2):​c.68-7T>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0025 in 1,611,588 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.0028 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0025 ( 12 hom. )

Consequence

BRCA2
NM_000059.4 splice_region, intron

Scores

2
Splicing: ADA: 0.01713
2

Clinical Significance

Benign reviewed by expert panel U:3B:33

Conservation

PhyloP100: 0.456

Publications

35 publications found
Variant links:
Genes affected
BRCA2 (HGNC:1101): (BRCA2 DNA repair associated) Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020]
BRCA2 Gene-Disease associations (from GenCC):
  • BRCA2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Fanconi anemia complementation group D1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • pancreatic cancer, susceptibility to, 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 13-32319070-T-A is Benign according to our data. Variant chr13-32319070-T-A is described in ClinVar as Benign. ClinVar VariationId is 52187.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00281 (428/152318) while in subpopulation AMR AF = 0.00719 (110/15298). AF 95% confidence interval is 0.0061. There are 1 homozygotes in GnomAd4. There are 251 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 12 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000059.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
NM_000059.4
MANE Select
c.68-7T>A
splice_region intron
N/ANP_000050.3A0A7P0T9D7
BRCA2
NM_001432077.1
c.68-7T>A
splice_region intron
N/ANP_001419006.1A0A7P0T9D7
BRCA2
NM_001406720.1
c.68-7T>A
splice_region intron
N/ANP_001393649.1A0A8V8TPZ2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
ENST00000380152.8
TSL:5 MANE Select
c.68-7T>A
splice_region intron
N/AENSP00000369497.3P51587
BRCA2
ENST00000544455.6
TSL:1
c.68-7T>A
splice_region intron
N/AENSP00000439902.1P51587
BRCA2
ENST00000530893.7
TSL:1
c.-302-7T>A
splice_region intron
N/AENSP00000499438.2A0A590UJI7

Frequencies

GnomAD3 genomes
AF:
0.00282
AC:
429
AN:
152200
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000458
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00720
Gnomad ASJ
AF:
0.0150
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.00659
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00223
Gnomad OTH
AF:
0.00430
GnomAD2 exomes
AF:
0.00287
AC:
712
AN:
247874
AF XY:
0.00294
show subpopulations
Gnomad AFR exome
AF:
0.000326
Gnomad AMR exome
AF:
0.00259
Gnomad ASJ exome
AF:
0.0134
Gnomad EAS exome
AF:
0.000219
Gnomad FIN exome
AF:
0.00634
Gnomad NFE exome
AF:
0.00242
Gnomad OTH exome
AF:
0.00232
GnomAD4 exome
AF:
0.00247
AC:
3603
AN:
1459270
Hom.:
12
Cov.:
32
AF XY:
0.00244
AC XY:
1768
AN XY:
725876
show subpopulations
African (AFR)
AF:
0.000930
AC:
31
AN:
33350
American (AMR)
AF:
0.00238
AC:
106
AN:
44544
Ashkenazi Jewish (ASJ)
AF:
0.0134
AC:
349
AN:
26104
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39670
South Asian (SAS)
AF:
0.00201
AC:
172
AN:
85666
European-Finnish (FIN)
AF:
0.00581
AC:
309
AN:
53206
Middle Eastern (MID)
AF:
0.00161
AC:
9
AN:
5578
European-Non Finnish (NFE)
AF:
0.00218
AC:
2421
AN:
1110850
Other (OTH)
AF:
0.00335
AC:
202
AN:
60302
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
178
357
535
714
892
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00281
AC:
428
AN:
152318
Hom.:
1
Cov.:
33
AF XY:
0.00337
AC XY:
251
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.000457
AC:
19
AN:
41576
American (AMR)
AF:
0.00719
AC:
110
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0150
AC:
52
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5192
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4824
European-Finnish (FIN)
AF:
0.00659
AC:
70
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00223
AC:
152
AN:
68024
Other (OTH)
AF:
0.00426
AC:
9
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
20
39
59
78
98
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00363
Hom.:
0
Bravo
AF:
0.00229
EpiCase
AF:
0.00311
EpiControl
AF:
0.00296

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
11
Breast-ovarian cancer, familial, susceptibility to, 2 (12)
-
1
5
not specified (6)
-
1
4
Hereditary breast ovarian cancer syndrome (5)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
3
not provided (3)
-
-
2
Familial cancer of breast (2)
-
-
1
BRCA2-related disorder (1)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Fanconi anemia complementation group D1 (1)
-
-
1
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
5.6
DANN
Benign
0.65
PhyloP100
0.46
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.017
dbscSNV1_RF
Benign
0.10
Splicevardb
3.0
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs81002830; hg19: chr13-32893207; COSMIC: COSV66457916; COSMIC: COSV66457916; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.